Jayson Bedford
Stock Analyst at Raymond James
(4.66)
# 822
Out of 4,595 analysts
730
Total ratings
59.6%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Maintained: Buy | $91 → $94 | $83.45 | +12.64% | 76 | Jul 31, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $83 → $100 | $85.01 | +17.63% | 46 | Jul 31, 2026 | |
| SYK Stryker | Maintained: Buy | $418 → $370 | $325.70 | +13.60% | 5 | Jul 31, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | n/a | $105.70 | - | 85 | Jul 17, 2026 | |
| ISRG Intuitive Surgical | Maintained: Buy | $603 → $483 | $353.33 | +36.70% | 16 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $209 → $265 | $256.35 | +3.37% | 69 | Jul 16, 2026 | |
| PODD Insulet | Maintained: Buy | $263 → $216 | $165.35 | +30.63% | 46 | Jun 8, 2026 | |
| TFX Teleflex | Maintained: Buy | $128 → $150 | $136.71 | +9.72% | 13 | May 8, 2026 | |
| AXGN Axogen | Maintained: Buy | $41 → $48 | $42.21 | +13.72% | 8 | Apr 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $124 → $88 | $46.73 | +88.32% | 76 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $93.93 | - | 9 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 | $86.07 | +11.54% | 30 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $17.69 | +7.41% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $85.39 | - | 29 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $180 | $168.51 | +6.82% | 59 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $5.03 | - | 26 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $26.16 | n/a | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.65 | n/a | 29 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $165.62 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.23 | n/a | 16 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $19.50 | n/a | 17 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $14.79 | n/a | 41 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 12 | Jul 23, 2019 |
DexCom
Jul 31, 2026
Maintained: Buy
Price Target: $91 → $94
Current: $83.45
Upside: +12.64%
Merit Medical Systems
Jul 31, 2026
Maintained: Buy
Price Target: $83 → $100
Current: $85.01
Upside: +17.63%
Stryker
Jul 31, 2026
Maintained: Buy
Price Target: $418 → $370
Current: $325.70
Upside: +13.60%
Abbott Laboratories
Jul 17, 2026
Maintained: Buy
Price Target: n/a
Current: $105.70
Upside: -
Intuitive Surgical
Jul 17, 2026
Maintained: Buy
Price Target: $603 → $483
Current: $353.33
Upside: +36.70%
Johnson & Johnson
Jul 16, 2026
Maintained: Buy
Price Target: $209 → $265
Current: $256.35
Upside: +3.37%
Insulet
Jun 8, 2026
Maintained: Buy
Price Target: $263 → $216
Current: $165.35
Upside: +30.63%
Teleflex
May 8, 2026
Maintained: Buy
Price Target: $128 → $150
Current: $136.71
Upside: +9.72%
Axogen
Apr 29, 2026
Maintained: Buy
Price Target: $41 → $48
Current: $42.21
Upside: +13.72%
Boston Scientific
Mar 27, 2026
Maintained: Buy
Price Target: $124 → $88
Current: $46.73
Upside: +88.32%
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $93.93
Upside: -
Nov 3, 2025
Upgraded: Buy
Price Target: $96
Current: $86.07
Upside: +11.54%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $17.69
Upside: +7.41%
Aug 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $85.39
Upside: -
Aug 8, 2025
Maintained: Buy
Price Target: $187 → $180
Current: $168.51
Upside: +6.82%
Aug 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $5.03
Upside: -
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $26.16
Upside: n/a
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $16.65
Upside: n/a
May 2, 2025
Downgraded: Hold
Price Target: n/a
Current: $165.62
Upside: n/a
Nov 16, 2023
Downgraded: Hold
Price Target: n/a
Current: $15.23
Upside: n/a
May 4, 2023
Maintained: Hold
Price Target: n/a
Current: $19.50
Upside: n/a
Apr 17, 2023
Maintained: Buy
Price Target: $14 → $13
Current: $14.79
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a